Demant A/S (OTCMKTS:WILYY) Cut to “Hold” at Sanford C. Bernstein

Demant A/S (OTCMKTS:WILYY) was downgraded by Sanford C. Bernstein from a “strong-buy” rating to a “hold” rating in a research report issued on Friday,Zacks.com reports.

Several other brokerages also recently issued reports on WILYY. Morgan Stanley upgraded Demant A/S from an “equal weight” rating to an “overweight” rating in a report on Tuesday, June 23rd. Zacks Research raised Demant A/S to a “hold” rating in a research report on Friday, June 26th. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy”.

Demant A/S Stock Performance

Shares of WILYY stock opened at $20.66 on Friday. The company has a debt-to-equity ratio of 1.65, a current ratio of 1.36 and a quick ratio of 1.00. The company’s fifty day simple moving average is $19.43 and its 200-day simple moving average is $16.86. Demant A/S has a 52 week low of $13.45 and a 52 week high of $20.98.

About Demant A/S

Demant A/S is a Denmark-based global hearing health care company specializing in the development, manufacture and distribution of hearing solutions and audiological diagnostic instruments. The company’s flagship brands include Oticon, Bernafon and Sonic, which offer a range of hearing aids designed to address various levels of hearing loss. In addition to personal hearing devices, Demant provides diagnostic equipment such as audiometers and tympanometers, supporting hearing care professionals in accurate assessment and fitting of hearing solutions.

Beyond hearing aids and diagnostics, Demant’s product portfolio extends to hearing implants—cochlear and bone-anchored systems—through its Oticon Medical division.